Evonik Enters into a Strategic Partnership with the University of Tokyo
Reinforced Innovation Activities in Growth Regions
The expansion of innovation activities in economically attractive regions supports Evonik’s growth strategy. The goal is to strengthen local customer competitiveness with technological services as well as research and application techniques that fit local needs.
An example in Asia is the R&D center in Shanghai (China) which was expanded in 2013 for the third time. In total, Evonik invested €23 million in the 14,000-square-meter building with 50 laboratories. Evonik’s Light & Electronics Project House is located in the renowned Industrial Technology Research Institute in Hsinchu (Taiwan), where research is carried out in the immediate vicinity of large production companies in the electronics industry.
The most central topics here are panel lighting, display components, and functional coatings. The project house has already made samples of newly developed opto-electronic applications available to potential customers for testing purposes.
Furthermore, Creavis, the strategic innovation unit of Evonik, opened a biotechnological research laboratory in Shanghai in 2013. Additionally, Evonik plans to further strengthen research in the NAFTA region, focusing on five Evonik sites. At the beginning of April, a project house was also launched here: This house will conduct research in the medical engineering field and is located in Birmingham (Alabama, USA), a site of the Health & Nutrition Business Unit.
Due to its strategic significance, Evonik has raised R&D expenditure by an average of 9 % a year since 2009. Expenditure amounted to €394 million in 2013, compared to €382 million in 2012. The R&D quota was 3.1 %. Expenditure on R&D is also expected to remain at a high level in the future.